Merton Carl A

Tilray CFO Merton buys 33,500 shares at $0.60 ($19.9K); repeats pattern of prior purchases that returned +775.0% and +905.4% within 30 days.

Merton Carl A, Tilray's CFO, purchased 33,500 shares at $0.60 on 2025-07-30, adding to a position that grew from 764,569 shares to 798,069 shares (+4.4%). The transaction price of $0.60 represents a sharp disconnect from the current price of $6.12, which itself sits -69.8% from the 52-week high of $20.30, suggesting either significant recovery since purchase or data-timing issues. More notable is the CFO's historical pattern at this ticker: his two prior TLRY purchases (2024-11-15 at unspecified price and 2024-01-12) both delivered outsized 30-day returns of +775.0% and +905.4% respectively, with corresponding 90-day returns of +593.6% and +916.0%. His cross-ticker track record shows an 100.00% win rate across 2 prior buys with an average 90-day return of +754.8%. This persistent pattern of well-timed entry points—both at TLRY and across his open-market history—stands in contrast to the company's fundamental weakness: net income of $-789.4M on quarterly revenue of $185.8M, with the company unprofitable over its most recent full fiscal year. The signal is not about valuation or conviction but rather a demonstrated repetition of a historically successful timing behavior at this specific security.

CFO Merton Carl A buys 26,000 shares of TLRY at $1.36; stock -53.7% from 52-week high, company unprofitable.

Merton Carl A, the Chief Financial Officer, purchased 26,000 shares at $1.36 on 2024-11-15, establishing his first holding at TLRY. The transaction occurs after the stock has declined -53.7% from its 52-week high of $28.50 and has fallen -17.0% over the prior 30 days. His prior buy at this ticker on 2024-01-12 delivered a 90-day return of +916.0%, marking a well-timed entry. However, the company's fundamental position remains challenged: it reported negative net income of $-39,165,000.00 on quarterly revenue of $200,044,000.00, and remained unprofitable over its most recent full fiscal year, despite annual revenue growth of +25.8%. The CFO's purchase into a significantly depressed stock price and a pattern of prior well-timed accumulation at the same ticker merit scrutiny, particularly given the company's lack of profitability and the steep recent price declines.